title: [Thrombocytopenia due to glibenclamide].
abstract: A 45-year-old male, admitted for severe thrombocytopenia and bleeding tendency related to treatment with glibenclamide is presented. Thrombocytopenic purpura associated with glibenclamide, a short-acting sulfonylurea, is rare. We suggest that platelet counts be performed shortly after initiation of glibenclamide administration, and every 3 months thereafter.
authors.affiliation: Dept. of Medicine A, Hillel Yaffe Medical Center, Hadera.
authors.forename: R
authors.initials: R
authors.lastname: Ganam
authors.forename: F
authors.initials: F
authors.lastname: Zidan
authors.forename: P
authors.initials: P
authors.lastname: Weiner
mesh_terms: D005905:Glyburide / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011696:Purpura, Thrombocytopenic / Q000139:chemically induced*
chemical_list: D005905:Glyburide